secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2026-09-29T21:16:14+00:00
Accession:  0001193125-26-407817
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

BioAtla CMO Eric Sievers resigns; board reinstates CEO/CFO retention bonuses tied to capital-raising milestones
--------------------------------------------------------------------------------

- Dr. Eric Sievers resigned as Chief Medical Officer on Sept 25, 2026 to pursue outside interests; he continues as a consultant through June 30, 2027.
- Sievers' consulting deal pays a one-time $159,000 contingent on capital-raising milestones by Dec 31, 2026, then an hourly rate from Jan 1 to June 30, 2027.
- CFO Christian Vasquez retention bonus reinstated at $148,888 target (40% of base salary) for Milestone #2 by Dec 31, 2026; 80-120% sliding scale, payable by Jan 31, 2027.
- CEO Jay Short's retention bonus of $440,892 (60% of base) requires 100% milestone achievement by Dec 31, 2026 with no sliding scale; payable by Jan 30, 2027.
- New performance bonuses approved Sept 24: $220,000 target for Short, $75,000 for Vasquez, tied to milestones by March 31, 2027 and payable by April 30, 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000119312526407817/0001193125-26-407817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000119312526407817/bcab-20260923.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-407817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer